08:20-09:00     Registration

09:00-09:20     Welcome Remarks

                          挨拶

09:20-12:20     Session I.  Pharmaceutical Regulation

1. Updated Taiwan Pharmaceutical Regulation
    台湾の最近の薬事事情

2. Current Activity of Review System in Japan
    日本の審査システムの現状について

3. Current Status of Japanese Pharmaceutical Industry after PAL Reform
        日本の薬事法改正後の製薬産業の現状

4. Current Situation of Taiwanese GMP and Inspection
    台湾のＧＭＰ及び査察の現状

5. Current Status of Inspection System in Japan
    日本の査察システムの現状

6. Prospect of Medical Device Regulatory Environment in Taiwan
    台湾の最近の医療機器規制

7. Certification of Medical Device in Japan
    日本の医療機器販売証明

12:20-13:30     Lunch

13:30-16:10     Session II. Change of Environment for Activating Clinical  Trials & Participation in Multi-National Clinical Study

8. Current Status of Clinical Trials in Taiwan
    台湾における臨床試験の現状

9. Challenges for Drug Development in Japan
    日本の医薬品開発に向けて

10 Current Status of Multi-National Clinical Trials in Taiwan       
     台湾における国際共同治験の現状

11Opportunity and Challenge in Participating Multi-National Clinical Trials in Japan
    日本における国際共同治験の現状

16:10-17:10     Panel Discussion

          Asian Collaboration in Clinical Study
          国際同時開発臨床データの相互利用

17:10-17:30     Closing Remarks
          閉会の挨拶